Instrument NameHims & Hers Health IncInstrument Symbol(HIMS-N)

Instrument ExchangeNYSE

The company expects to enjoy many GLP-1 tailwinds in 2025.

Disrupting pharmacies is just the start for Hims & Hers.

Despite the stock market trading at new all-time highs, institutions still find enough reason to buy more enormous stakes in three stocks.

Hims & Hers Health Inc (HIMS) has been a standout performer in the stock market, experiencing an impressive 275% surge over the last 12 months. This remarkable gain positions the company at the forefront of growth in the Household & Personal Products sector. Let’s explore the reasons behind this growth...

The GLP-1 drama continues at Hims & Hers.

GLP-1s get all the attention, but Hims & Hers' core business is where the rocket growth is.

Is Hims & Hers in trouble since the FDA put a time clock on some GLP-1s, or is the future still bright?

Look beyond the stock price at the business when shares are volatile.

Consistently investing even moderate sums can grow your portfolio with time.

Big GLP-1 news could have an impact.

Three stocks reported a surge in call option buying recently, showing investors that there could be a path to more upside potential, analysts agree

There is now a new reason to look into Hims & Hers stock for additional upside, including the new addition to the S&P 600 index alongside double-digit growth.

Growth for its GLP-1 weight loss drugs continues to be robust.

Hims & Hers may not be hurt by GLP-1 news the way investors think.

These top stocks are on a winning streak and have the businesses to keep it going.

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down by -0.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.05%. Stocks fell moderately on Thursday, with the Dow Jones Industrials dropping...

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.77%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is off by -0.51%. Stocks are struggling to pick a direction ahead of Friday's key...

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.15%. Stocks today are moderately lower, with the Dow Jones Industrials falling...

Market-beating returns could be on the way for patient investors in these two up-and-coming healthcare growth stocks.

Buying a new pharmacy will allow Hims & Hers to expand into new markets.

Telemedicine once seemed like it was going to revolutionize healthcare.

The healthcare company will be making more of the product it sells.

Shares of Hims & Hers are falling even as the company has been posting some solid results.

Telemedicine was one of the most in-demand services during the height of the COVID-19 pandemic.

The risk-reward proposition is pretty one-sided here.